Stemcentrx Inc

Stemcentrx Inc. is a privately held biotechnology company headquartered in South San Francisco, California. The company employs 11 people and generates $17.8 million in annual revenue. Stemcentrx was founded in 2008 and focuses on developing innovative cancer therapies. Stemcentrx specializes in identifying cancer stem cells, discovering novel targets, engineering, and manufacturing antibodies and antibody drug conjugates. Their proprietary platforms are designed to eradicate cancer stem cells, ultimately aiming to cure and significantly improve the survival rates of cancer patients. Stemcentrx distinguishes itself with its state-of-the-art research and GMP manufacturing capabilities, allowing them to rapidly progress from target discovery to clinical trials. They cultivate a unique company culture characterized by a driven, ambitious, and collaborative environment, similar to that of Silicon Valley startups. For inquiries, visit Stemcentrx's website at stemcentrx.com.